Welcome to LookChem.com Sign In|Join Free

CAS

  • or

306-60-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 306-60-5 Structure
  • Basic information

    1. Product Name: AGMATINE SULFATE ENDOGENOUS AGONIST AT
    2. Synonyms: AGMATINE SULFATE ENDOGENOUS AGONIST AT;1-(4-aminobutyl)guanidine;2-(4-aminobutyl)guanidine;(4-Aminobutyl) guanidine;N1-(4-Aminobutyl)guanidine;2-(4-azanylbutyl)guanidine;4-Guanidino-1-butanamine;N-(4-Aminobutyl)guanidine
    3. CAS NO:306-60-5
    4. Molecular Formula: C5H14N4
    5. Molecular Weight: 130.19146
    6. EINECS: 206-187-7
    7. Product Categories: N/A
    8. Mol File: 306-60-5.mol
    9. Article Data: 11
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 235℃
    3. Flash Point: 96℃
    4. Appearance: powder
    5. Density: 1.20
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. PKA: 13.78±0.70(Predicted)
    10. CAS DataBase Reference: AGMATINE SULFATE ENDOGENOUS AGONIST AT(CAS DataBase Reference)
    11. NIST Chemistry Reference: AGMATINE SULFATE ENDOGENOUS AGONIST AT(306-60-5)
    12. EPA Substance Registry System: AGMATINE SULFATE ENDOGENOUS AGONIST AT(306-60-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 306-60-5(Hazardous Substances Data)

306-60-5 Usage

Description

Agmatine sulfate endogenous agonist AT is a naturally occurring compound in the human body, derived from the amino acid arginine and functioning as a neurotransmitter. It acts as an endogenous agonist at imidazoline receptors and possesses a broad spectrum of potential therapeutic effects, such as anti-anxiety, antidepressant, and pain-relieving properties. Additionally, it plays a role in regulating nitric oxide synthesis and is believed to have antioxidant and neuroprotective effects. Its ability to modulate various neurotransmitter systems in the brain makes it a promising target for the treatment of various neuropsychiatric and neurodegenerative disorders.

Uses

Used in Pharmaceutical Industry:
Agmatine sulfate endogenous agonist AT is used as a therapeutic agent for its potential anti-anxiety, antidepressant, and pain-relieving properties. Its neuroprotective and antioxidant effects also make it a promising candidate for the treatment of neuropsychiatric and neurodegenerative disorders.
Used in Neurological Research:
Agmatine sulfate endogenous agonist AT is used as a research tool to study the modulation of neurotransmitter systems in the brain and its potential role in the treatment of various neurological conditions.
Used in Nutraceutical Industry:
Agmatine sulfate endogenous agonist AT is used as a dietary supplement to support cognitive health and promote overall brain function, given its neuroprotective and antioxidant properties.
Used in Cosmetic Industry:
Agmatine sulfate endogenous agonist AT may be used in cosmetic products for its potential skin-protective and antioxidant effects, contributing to skin health and rejuvenation.

Check Digit Verification of cas no

The CAS Registry Mumber 306-60-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,0 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 306-60:
(5*3)+(4*0)+(3*6)+(2*6)+(1*0)=45
45 % 10 = 5
So 306-60-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9)

306-60-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name agmatine

1.2 Other means of identification

Product number -
Other names N-4-Aminobutylguanidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:306-60-5 SDS

306-60-5Synthetic route

S-n-propylisothiourea
2986-21-2

S-n-propylisothiourea

1,4-diaminobutane
110-60-1

1,4-diaminobutane

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
at 80℃; for 0.75h;96%
N-Benzyloxycarbonyl-NG-nitroagmatin
23441-10-3

N-Benzyloxycarbonyl-NG-nitroagmatin

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With formic acid; palladium on activated charcoal In methanol for 2h; Ambient temperature;52%
With formic acid; palladium on activated charcoal In methanol at 25℃; for 2h; Yield given;
L-arginine
74-79-3

L-arginine

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
durch Escherichia coli;
With Escherichia coli
With E.coli; streptococcus faecalis bei pH 4;
With L-arginine decarboxylase; pyridoxal 5'-phosphate; diothiothreitol In phosphate buffer at 50℃; for 0.166667h; pH=6.5;
With 3,5,5-Trimethylcyclohex-2-en-1-one In isopropyl alcohol at 150℃; for 4h; Autoclave;
CYANAMID
420-04-2

CYANAMID

1,4-diaminobutane
110-60-1

1,4-diaminobutane

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With water
With barium sulfate
2-methylisothiourea sulphate
14527-26-5, 867-44-7

2-methylisothiourea sulphate

1,4-diaminobutane
110-60-1

1,4-diaminobutane

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

3,5-Dimethylpyrazole-1-carboxamidine
22906-75-8

3,5-Dimethylpyrazole-1-carboxamidine

N-benzyloxycarbonyl-1,4-butanediamine hydrochloride
18807-73-3

N-benzyloxycarbonyl-1,4-butanediamine hydrochloride

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
(i) aq. NaOH, EtOH, (ii) aq. HBr; Multistep reaction;
arcain

arcain

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With saprophytes
With barium dihydroxide; water
herring-milt

herring-milt

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With sulfuric acid Hydrolysis;
cyanamide silver

cyanamide silver

hydrochloride of tetramethylenediamine

hydrochloride of tetramethylenediamine

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With carbon dioxide; water
1,4-diaminobutane
110-60-1

1,4-diaminobutane

S-methyl-thiuronium-sulfate

S-methyl-thiuronium-sulfate

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With water
agmatine sulphate
2482-00-0

agmatine sulphate

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
With tetramethyl ammoniumhydroxide In methanol for 1h;
S-methylthiopseudourea.H2 SO4

S-methylthiopseudourea.H2 SO4

1,4-diaminobutane
110-60-1

1,4-diaminobutane

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Conditions
ConditionsYield
In water
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

(4R*,5R*)-5-diisopropyloxyphosphoryl-5-methyl-4-(succinimidyloxycarbonyloxymethyl)-1-pyrroline N-oxide

(4R*,5R*)-5-diisopropyloxyphosphoryl-5-methyl-4-(succinimidyloxycarbonyloxymethyl)-1-pyrroline N-oxide

5-(diisopropyloxyphosphoryl)-5-methyl-4-[({[2-(guanidino)buthyl]carbamoyl}oxy)methyl]-5-methyl-1-pyrroline N-oxide

5-(diisopropyloxyphosphoryl)-5-methyl-4-[({[2-(guanidino)buthyl]carbamoyl}oxy)methyl]-5-methyl-1-pyrroline N-oxide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile95%
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

mitomycin A
4055-39-4

mitomycin A

C20H29N7O5
103095-05-2

C20H29N7O5

Conditions
ConditionsYield
In methanol70%
indole-3-acetic acid
87-51-4

indole-3-acetic acid

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

β-naphthaldehyde
66-99-9

β-naphthaldehyde

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N-(4-guanidinobutyl)-2-(1H-indol-3-yl)-N-((naphthalen-2-yl)methyl)acetamide trifluoroacetic acid salt
949592-43-2

N-(4-guanidinobutyl)-2-(1H-indol-3-yl)-N-((naphthalen-2-yl)methyl)acetamide trifluoroacetic acid salt

Conditions
ConditionsYield
Multistep reaction.;26%
4-indol-3-yl-butyric acid
133-32-4

4-indol-3-yl-butyric acid

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

β-naphthaldehyde
66-99-9

β-naphthaldehyde

trifluoroacetic acid
76-05-1

trifluoroacetic acid

N-(4-guanidinobutyl)-4-(1H-indol-3-yl)-N-((naphthalen-2-yl)methyl)butanamide trifluoroacetic acid salt
949592-47-6

N-(4-guanidinobutyl)-4-(1H-indol-3-yl)-N-((naphthalen-2-yl)methyl)butanamide trifluoroacetic acid salt

Conditions
ConditionsYield
Multistep reaction.;24%
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

2-[4-(4-chlorobenzoyl)-phenoxy]-2-methylpropionyl chloride
65178-90-7

2-[4-(4-chlorobenzoyl)-phenoxy]-2-methylpropionyl chloride

2-(4-(4-chlorobenzoyl)phenoxy)-N-(4-guanidinobutyl)-2-methylpropanamide
1094098-88-0

2-(4-(4-chlorobenzoyl)phenoxy)-N-(4-guanidinobutyl)-2-methylpropanamide

Conditions
ConditionsYield
With pyridine10%
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

2-hydroxy-2-phenylacetophenone
119-53-9

2-hydroxy-2-phenylacetophenone

N1-(4,5-Diphenyl-1H-imidazol-2-yl)-butane-1,4-diamine

N1-(4,5-Diphenyl-1H-imidazol-2-yl)-butane-1,4-diamine

Conditions
ConditionsYield
With potassium hydroxide; 2-hydroxyethanethiol; sodium sulfite In water at 100℃; for 0.166667h;
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

γ-guanidino butyraldehyde
14049-14-0

γ-guanidino butyraldehyde

Conditions
ConditionsYield
With potassium phosphate buffer (pH: 7.0) at 35℃; for 0.333333h; agmatine oxidase from Penicillium chrysogenum;
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

calcium permanganate

calcium permanganate

A

succinic acid
110-15-6

succinic acid

B

4-guanidinobutyric acid
463-00-3

4-guanidinobutyric acid

C

guanidine nitrate
113-00-8

guanidine nitrate

Conditions
ConditionsYield
bei der Oxydation;
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

p-ethylbenzoyl chloride
16331-45-6

p-ethylbenzoyl chloride

p-aminoethylbenzoate
94-09-7

p-aminoethylbenzoate

C21H27N5O2

C21H27N5O2

Conditions
ConditionsYield
Multistep reaction;
diethylenetriaminepentaacetic dianhydride
23911-26-4

diethylenetriaminepentaacetic dianhydride

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

diethylenetriamine-N,N''-bis(4-guanidinobutyl)-N,N',N''-triacetic acid
616205-57-3

diethylenetriamine-N,N''-bis(4-guanidinobutyl)-N,N',N''-triacetic acid

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 50℃; for 4h;
In dimethyl sulfoxide at 50℃; for 10h;
In dimethyl sulfoxide at 20 - 50℃; for 24h;
C24H24FN3O6

C24H24FN3O6

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

C29H38FN7O5

C29H38FN7O5

Conditions
ConditionsYield
With sodium tris(acetoxy)borohydride; acetic acid In methanol; dichloromethane at 25℃; for 12h;
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Cholesteryl chloroformate
7144-08-3

Cholesteryl chloroformate

agmatinyl carboxycholesterol acetic acid salt

agmatinyl carboxycholesterol acetic acid salt

Conditions
ConditionsYield
Stage #1: 1-(4-aminobutyl)guanidine; Cholesteryl chloroformate In DMF (N,N-dimethyl-formamide) at 20℃; for 72h;
Stage #2: With acetic acid
poly(NHS-acrylate)

poly(NHS-acrylate)

1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

Poly(guanidinobutylacrylamide)

Poly(guanidinobutylacrylamide)

Conditions
ConditionsYield
In water; isopropyl alcohol
In water; isopropyl alcohol
1-(4-aminobutyl)guanidine
306-60-5

1-(4-aminobutyl)guanidine

2-(n-octyl)cyclopropanecarbonyl chloride
52355-54-1

2-(n-octyl)cyclopropanecarbonyl chloride

1-(2-n-octylcyclopropanecarboxamido)-4-guanidinobutane
117414-73-0

1-(2-n-octylcyclopropanecarboxamido)-4-guanidinobutane

Conditions
ConditionsYield
In pyridine; methanol; chloroform

306-60-5Relevant articles and documents

Hettinger et al.

, p. 4153,4154-4155 (1968)

ACTIVITY-ENHANCING SUPPLEMENT

-

, (2018/09/24)

An activity-enhancing supplement can include niacin and at least two ingredients selected from citrulline, agmatine, an endurance enhancer, a counteracting agent, a nitrogen-containing compound, a muscle building component, branched chain amino acid, and combinations thereof.

Further insight into the inhibitory action of a LIM/double zinc-finger motif of an agmatinase-like protein

Cofre, Jaime,Montes, Paola,Vallejos, Alejandro,Benítez, José,García, David,Martínez-Oyanedel, José,Carvajal, Nelson,Uribe, Elena

, p. 92 - 95 (2014/03/21)

Agmatine is a precursor for polyamine biosynthesis also associated to neurotransmitter, anticonvulsant, antineurotoxic and antidepressant actions in the brain. It results from decarboxylation of l-arginine by arginine decarboxylase and it is hydrolyzed to urea and putrescine by agmatinase. Recently, we have described a new protein which also hydrolyzes agmatine although its sequence greatly differs from all known agmatinases. This agmatinase-like protein (ALP) contains a LIM-like double Zn-finger domain close to its carboxyl terminus, whose removal results in a truncated variant with a 10-fold increased kcat, and a 3-fold decreased Km value for agmatine. Our proposal was that the LIM-domain functions as an autoinhibitory, regulatory entity for ALP. Results in this report provide additional support for the postulated inhibitory effect. The purified isolated LIM domain was shown to be competitively inhibitory to a truncated variant ALP (lacking the LIM-domain), but not to the wild-type species. The C453A variant was shown to be a Zn2 +-free enzyme with kinetic parameters similar to those of the truncated-ALP. A molecular dynamic simulation of a modeled LIM-domain 3D structure showed that, as a consequence of C453A mutation, the coordination of the zinc ion is broken and the structure of the zinc finger is melted. The inhibitory action of the LIM/double Zinc-finger motif was associated to a significant conformational change, as detected by tryptophan fluorescence studies, but was not related to changes in the association of the enzyme with the catalytically essential Mn2 +.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 306-60-5